Latest Conference Articles

With the weather getting warmer stinging insects like bees and wasps are becoming more of a concern for people with allergies or potential allergies. How these conditions are treated can make a significant difference in the time following stings.

If previous research has shown a correlation between chronic pain and depression, it's only natural that the same can be said about chronic pain and happiness – right? A new study shows that's not the case.

Obesity associated with metabolic syndrome can be treated when patients adhere to a high-protein diet, a team of researchers from University of California, Los Angeles found.

Food allergies are an ever growing concern for doctors in a wide range of specialties and now there are new conditions for them to consider when looking to make a proper diagnosis.

There are medications which can all but cure hepatitis C but for those patients who have not yet beaten the condition there is research that shows a link to developing cancer.

As work continues to be done to find the best ways to use new technology the question of what the next advancement will be is already setting the stage for the future of patient care.

Patients with long-standing ulcerative colitis have shown signs of being more at risk for developing cancer. Research has looked at why that is the case and what can be done to prevent the cancer from progressing.

Patients with gastroparesis may be helped with a combination of gastric electrical stimulation and surgery to widen the pylorus, a Texas team reports.

Gastroenterologist Venkat Subramanian, MD, discusses the use of high-definition screens and dyes during endoscopy to detect cancerous and noncancerous lesions in patients with ulcerative colitis

Patients who are obese may have a genetic makeup that causes their stomachs to empty faster than those of normal-weight people. Investigators say there is a drug that can help.

Opioid addiction is a serious problem that a subset of patients prescribed opioids for pain could face; however, the issue presents an even more slippery slope for those with chronic pain due to the long-term need for the drugs.

Treating hepatitis C with new antivirals saves lives and-in the long run-money spent on patient care. But some patients and their physicians are learning there are barriers to getting prescriptions approved by patients' insurance carriers.

Antony Loebel, MD, Executive Vice President and Chief Medical Officer, Sunovion Pharmaceuticals Inc. provided invaluable insight on the first placebo-controlled trial for patients with Major Depressive Disorder with mixed features.

Patients' levels of anxiety and defensiveness are associated with how they view their chronic back pain, a new study showed.

African Americans are more likely to be infected with the hepatitis C virus than Caucasians. But that does not mean they are more likely to die from the disease, researchers reported at the 2015 Digestive Disease Week conference in Washington, DC.

A relatively higher rate of hepatitis C infection in US adults considered to be part of the baby boom generation is starting to decline, researchers report. The statistical drop started the year after a CDC push for all US adults to get tested.

A recent study found that while most insurers are paying for the new hepatitis C antivirals, disparities exist. More than 20% of patients at the hospital studied who had private insurance were refused their prescriptions for sofosbuvir with simeprevir, the researchers found.

A drug that shows promise in protecting the human gut microbiome from antiobiotic assaults that can lead to C. difficile infection is about to enter Phase 2 trials. So far, it has worked well in lab pigs, researchers said at Digestive Disease Week 2015.

Reducing unnecessary lab tests in the intensive care unit is possible, a team of researchers from New York reported at the 2015 American Thoracic Society meeting in Denver, CO.

Edward Damiano, PhD, Professor of Biomedical Engineering, Boston University shared his 2013-2015 research results surrounding the acclaimed bionic pancreas at the 24th American Association of Clinical Endocrinologists Nashville, TN.

Henry Nasrallah, MD, Sydney W. Souers Endowed Chair, Professor & Chairman, Department of Neurology & Psychiatry, Saint Louis University School of Medicine introduced his research surrounding Parkinson's Disease Psychosis, often considered a new battle field for many psychiatrists.

Reporting at the 2015 Digestive Disease Week conference in Washington, DC, a research team from Scott and White Memorial Hospital in Temple, Texas, found that colonoscopy has the edge over upper endoscopy in fecal microbiota transplant.

Transplanting a healthy person's fecal microbiota into the digestive tract of a patient believed to have a recurrent C. difficile infection has gone from obscurity to an accepted treatggggment. But a new study finds it was wrongly proposed for more than 25% of patients referred for treatment.

The proximal and distal colon act like two different organs when it comes to biological function and the microbiota that live there. The difference is seen even at the gene transcriptional level and response to vitamin D, a team of researchers from the University of Chicago reported.

Some intestinal bacteria cause more pain than others in patients with irritable bowel syndrome, according to study results reported by a team of researchers from North Carolina.

With the incidence and severity of Clostridium difficile infection increasing every year, the growing acceptance of fecal transplant as a viable treatment may mean stool banks will become as common as sperm and blood banks.

For patients with C. difficile infection, fecal micriobiota transplantation may be their best bet when medication is not effective. Even as transplant becomes a more accepted approach for treating C. diff infection, researchers are investigating other areas it can be applied to.

Testosterone Replacement Therapy may be the way to go for some patients, but for others bioidenticals and other medications may provide better treatment over a shorter period of time.

There may be no shortage of stool around the world, but finding potential donors for fecal micriobiota transplant is a much more involved process. Research has shown that only 4% of people are viable for the process.

Men may not always want to go to the doctor but for an issue like low testosterone seeking treatment can make a considerable difference in their daily quality of life.